Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02503618 · ClinicalTrials.gov registry record
Understanding Substance Use and Incident HIV/STI Among Young Black MSM
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 469
- Enrollment target
NCT02503618: Completed study, sponsored by Emory University.
NCT02503618 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 469 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02503618 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 469 participants
- Enrollment target
Study Summary
The scientific purpose of this study is to look at how substance use may relate to human immunodeficiency virus (HIV) infection among young black men who have sex with men in Atlanta.
Primary Outcome
Prevalence of drug use and association between these factors and HIV seroconversion (hazard ratio)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-03-18 |
What the finished NCT02503618 record still lists
NCT02503618 is an observational study that tracks outcomes without assigning an intervention. The registered 469 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02503618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02503618 about?
NCT02503618 is a clinical study titled "Understanding Substance Use and Incident HIV/STI Among Young Black MSM". The scientific purpose of this study is to look at how substance use may relate to human immunodeficiency virus (HIV) infection among young black men who have sex with men in Atlanta.
What is the current status of trial NCT02503618?
This trial is currently completed. The enrollment target is 469 participants. The study started on 2015-07. Estimated completion is 2019-03-18.
Who is sponsoring clinical trial NCT02503618?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia